Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia

BACKGROUND: The aim of this study was to assess whether minimal residual disease (MRD) at the end of induction front-line treatment can serve as a surrogate endpoint for event-free survival (EFS) in childhood B-lineage acute lymphoblastic leukemia. METHODS: The analysis was based on individual data...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JNCI Cancer Spectr
Main Authors: Galimberti, Stefania, Devidas, Meenakshi, Lucenti, Ausiliatrice, Cazzaniga, Giovanni, Möricke, Anja, Bartram, Claus R, Mann, Georg, Carroll, William, Winick, Naomi, Borowitz, Michael, Wood, Brent, Basso, Giuseppe, Conter, Valentino, Zimmermann, Martin, Suciu, Stefan, Biondi, Andrea, Schrappe, Martin, Hunger, Stephen P, Valsecchi, Maria Grazia
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6649800/
https://ncbi.nlm.nih.gov/pubmed/31360884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pky069
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki